Protein glycosylation is an important post-translational modification of monoclonal antibodies that affects their therapeutic efficacy and immunogenicity.
Using flexible workflows for glycan relative quantitation, the Agilent 6545XT AdvanceBio LC/Q-TOF characterizes antibody glycoforms at four different analytical levels.
Download this application note to learn more about this approach.
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
© 2019 Technology Networks
All rights reserved